146 related articles for article (PubMed ID: 28439897)
1. Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors.
Sumner SM; Naskou MC; Thoresen M; Copland I; Peroni JF
Transfusion; 2017 Jul; 57(7):1755-1762. PubMed ID: 28439897
[TBL] [Abstract][Full Text] [Related]
2. Comparison of humoral insulin-like growth factor-1, platelet-derived growth factor-BB, transforming growth factor-β1, and interleukin-1 receptor antagonist concentrations among equine autologous blood-derived preparations.
Ionita CR; Troillet AR; Vahlenkamp TW; Winter K; Brehm W; Ionita JC
Am J Vet Res; 2016 Aug; 77(8):898-905. PubMed ID: 27463555
[TBL] [Abstract][Full Text] [Related]
3. Platelet lysate as a novel serum-free media supplement for the culture of equine bone marrow-derived mesenchymal stem cells.
Naskou MC; Sumner SM; Chocallo A; Kemelmakher H; Thoresen M; Copland I; Galipeau J; Peroni JF
Stem Cell Res Ther; 2018 Mar; 9(1):75. PubMed ID: 29566772
[TBL] [Abstract][Full Text] [Related]
4. Growth factors and cytokines in autologous platelet concentrate and their correlation to periodontal regeneration outcomes.
Christgau M; Moder D; Hiller KA; Dada A; Schmitz G; Schmalz G
J Clin Periodontol; 2006 Nov; 33(11):837-45. PubMed ID: 17018133
[TBL] [Abstract][Full Text] [Related]
5. Plateletpheresis does not cause long-standing platelet-derived growth factor release into the donor blood.
Zimmermann R; Loew D; Weisbach V; Strasser E; Ringwald J; Zingsem J; Eckstein R
Transfusion; 2005 Mar; 45(3):414-9. PubMed ID: 15752160
[TBL] [Abstract][Full Text] [Related]
6. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count.
Weibrich G; Kleis WK; Hafner G; Hitzler WE
J Craniomaxillofac Surg; 2002 Apr; 30(2):97-102. PubMed ID: 12069512
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hematologic values and transforming growth factor-beta and insulin-like growth factor concentrations in platelet concentrates obtained by use of buffy coat and apheresis methods from equine blood.
Sutter WW; Kaneps AJ; Bertone AL
Am J Vet Res; 2004 Jul; 65(7):924-30. PubMed ID: 15281650
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
Woodall WJ; Nguyen VQ; Tran MH
J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
[TBL] [Abstract][Full Text] [Related]
9. Standardization of a Protocol for Obtaining Platelet Rich Plasma from blood Donors; a Tool for Tissue Regeneration Procedures.
Gómez LA; Escobar M; Peñuela O
Clin Lab; 2015; 61(8):973-80. PubMed ID: 26427141
[TBL] [Abstract][Full Text] [Related]
10. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
[TBL] [Abstract][Full Text] [Related]
11. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
[TBL] [Abstract][Full Text] [Related]
12. Influence of cryopreservation and mechanical stimulation on equine Autologous Conditioned Plasma (ACP®).
Mageed M; Ionita C; Kissich C; Brehm W; Winter K; Ionita JC
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2015; 43(2):97-104. PubMed ID: 25782443
[TBL] [Abstract][Full Text] [Related]
13. Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture.
Hagen A; Lehmann H; Aurich S; Bauer N; Melzer M; Moellerberndt J; Patané V; Schnabel CL; Burk J
Front Bioeng Biotechnol; 2020; 8():613621. PubMed ID: 33553119
[TBL] [Abstract][Full Text] [Related]
14. Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis.
Zimmermann R; Reske S; Metzler P; Schlegel A; Ringwald J; Eckstein R
Vox Sang; 2008 Jul; 95(1):20-5. PubMed ID: 18444946
[TBL] [Abstract][Full Text] [Related]
15. The effect of plateletpheresis on the Fenwal CS-3000 on donor platelet counts.
Kalish RI; Chambers LA; Linden JV
J Clin Apher; 1987; 3(4):230-4. PubMed ID: 3680195
[TBL] [Abstract][Full Text] [Related]
16. [Plateletpheresis with the new cell separator A 201 (Baxter)].
Luboldt W; Moog R
Beitr Infusionsther; 1991; 28():195-200. PubMed ID: 1725618
[TBL] [Abstract][Full Text] [Related]
17. Platelet Yield and Some Donor-Related Predictors in a Single Donor Apheresis: Report from a Nigerian Tertiary Hospital.
Ugwu GC; Okoye HC; Nnachi OC; Nwani E; Nnachi OA; Ezenwenyi IP; Ugwu NI; Okoye AE
West Afr J Med; 2022 Dec; 39(12):1280-1284. PubMed ID: 36583368
[TBL] [Abstract][Full Text] [Related]
18. Plateletpheresis-induced increase in platelet reactivity using different cell separators.
Jung F; Bläsi U; Radtke H; Mrowietz C; Pindur G; Kiesewetter H; Wenzel E
Infusionsther Transfusionsmed; 1995 Aug; 22(4):237-43. PubMed ID: 7496123
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructure and growth factor content of equine platelet-rich fibrin gels.
Textor JA; Murphy KC; Leach JK; Tablin F
Am J Vet Res; 2014 Apr; 75(4):392-401. PubMed ID: 24669926
[TBL] [Abstract][Full Text] [Related]
20. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
Tondon R; Pandey P; Chaudhry R
J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
